You have 9 free searches left this month | for more free features.

Seoul (1)

Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor (1)

Recruiting (1)

phase 2 (1)

Yonsei University (1)

Takeda (1)

niraparib-bevacizumab (1)

drug (1)

Other (1)

Interventional (1)

niraparib-bevacizumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor

Jul 6, 2021